Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways
| Autor: | Edelmann, Jennifer, Dokal, Arran D., Vilventhraraja, Emma, Holzmann, Karlheinz, Britton, David, Klymenko, Tetyana, Döhner, Hartmut, Cragg, Mark, Braun, Andrejs, Cutillas, Pedro, Gribben, John G. |
|---|---|
| Zdroj: | In iScience 19 February 2021 24(2) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|